As the bivalent booster season kicks off in earnest, a new study published yesterday from NYU researchers identifies two cases of mutated coronavirus resistant to Gilead’s remdesivir in immunocompromised individuals.
The two patients in their 50s and 60s had both undergone kidney transplants (and were both…
